Showing results (71-80 of 163) with videos related to

Sort By:
Pageof 17
Journal of Pharmacokinetics and Pharmacodynamics|July 1, 2006
Diazepam pharamacokinetics from preclinical to phase I using a Bayesian population physiologically based pharmacokinetic model with informative prior distributions in WinBUGSIvelina Gueorguieva, Leon Aarons, Malcolm Rowland
Pharmaceutical Research|April 2, 2013
A physiologically based pharmacokinetic model for strontium exposure in ratHenry Pertinez, Marylore Chenel, Leon Aarons
Clinical Pharmacology and Therapeutics|June 2, 2022
Coproporphyrin I as an Endogenous Biomarker to Detect Reduced OATP1B Activity and Shift in Elimination Route in Chronic Kidney DiseaseHiroyuki Takita, Daniel Scotcher, Xiaoyan Chu, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 25, 2012
Population pharmacokinetic modelling of S-warfarin to evaluate the design of drug-drug interaction studies for CYP2C9Kerenaftali Klein, Ivelina Gueorguieva, Leon Aarons
The Journal of Pharmacy and Pharmacology|February 22, 2005
A pharmacokinetic/pharmacodynamic model for a platelet activating factor antagonist based on data arising from Phase I studiesLynne Evans, Leon Aarons, Chris Brearley
Pharmaceutical Research|May 6, 2014
Handling missing data in a duloxetine population pharmacokinetic/pharmacodynamic model - imputation methods and selection modelsEunice Yuen, Ivelina Gueorguieva, Leon Aarons
Biopharmaceutics & Drug Disposition|July 13, 2004
Pharmacodynamics of controlled release verapamil in patients with hypertension: an analysis using spline functionsLeon Aarons, Claire Baxter, Suneel Gupta
The Journal of Pharmacology and Experimental Therapeutics|October 14, 2018
Comprehensive Evaluation of the Utility of 20 Endogenous Molecules as Biomarkers of OATP1B Inhibition Compared with Rosuvastatin and Coproporphyrin IShelby Barnett, Kayode Ogungbenro, Karelle Ménochet, et al.
European Journal of Clinical Pharmacology|June 8, 2019
A population pharmacokinetic model for simvastatin and its metabolites in children and adolescentsKayode Ogungbenro, Jonathan B Wagner, Susan Abdel-Rahman, et al.
Molecular Pharmaceutics|June 17, 2025
Challenges and Opportunities for Incorporating Physiological Information into Pharmacokinetic Models of Intranasal Drug Delivery to the Brain: A Review of the Current Status and Future TrajectoriesSaeed Rezaee, Zubida M Al-Majdoub, Aleksandra Galetin, et al.
Pageof 17